What is Intagras?
Intagras operates at the intersection of life sciences and regulatory technology, providing sophisticated software solutions designed to navigate the complexities of global product labeling and safety compliance. By offering specialized tools such as the Tracking Portal and SPL Portal, the company enables pharmaceutical enterprises to automate critical submission workflows and maintain rigorous adherence to international standards. Their value proposition is rooted in the integration of automated markup capabilities with expert-led outsourcing services, effectively reducing the operational burden on regulatory teams. As the industry faces increasing pressure for transparency and data accuracy, Intagras serves as a vital infrastructure partner for organizations seeking to streamline their regulatory lifecycle management.
How much funding has Intagras raised?
Intagras has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Intagras
PPP
Public-Private Partnership
What's next for Intagras?
With the infusion of this recent capital, Intagras is poised to transition into a phase of aggressive scaling and technological refinement. The strategic focus will likely center on enhancing the interoperability of their existing platforms and potentially expanding their service offerings to address emerging regulatory requirements in new geographic markets. By leveraging this financial momentum, the company aims to solidify its status as a leader in regulatory tracking, ensuring that its clients remain compliant in an increasingly volatile global environment. Future growth will be driven by the continued adoption of their automated submission tools and the expansion of their expert support network, which remains a cornerstone of their competitive advantage.
See full Intagras company page
